Lili Li
@curatorlili.bsky.social
Minimal Residue Disease Monitoring
Natera’s technology will be featured across multiple presentations at #ESMO2025. See the full schedule below and stop by booth #1016 to learn more. #Natera #MRD #Signatera
@myesmo.bsky.social
@myesmo.bsky.social
October 20, 2025 at 7:35 PM
Minimal Residue Disease Monitoring
Reposted by Lili Li
Join our upcoming webinar w/ Katie Hashimoto, MS, CGC, Chris Sullivan, MD, FACOG & Dr. Shailen Shah, MD.
Review the latest advancements and unique capabilities of SNP-based NIPT and explore real-world case studies.
Register today: ow.ly/u9B650WX48I
Review the latest advancements and unique capabilities of SNP-based NIPT and explore real-world case studies.
Register today: ow.ly/u9B650WX48I
Upcoming Webinar
NIPT Evolved: New insights, real cases, and better decisions
ow.ly
September 15, 2025 at 8:02 PM
Join our upcoming webinar w/ Katie Hashimoto, MS, CGC, Chris Sullivan, MD, FACOG & Dr. Shailen Shah, MD.
Review the latest advancements and unique capabilities of SNP-based NIPT and explore real-world case studies.
Register today: ow.ly/u9B650WX48I
Review the latest advancements and unique capabilities of SNP-based NIPT and explore real-world case studies.
Register today: ow.ly/u9B650WX48I
We’re pleased to announce that our genome-based Signatera MRD assay is now covered by Medicare.
This is an exciting milestone as we continue advancing precision oncology and expanding access to innovative technology. ow.ly/KQcR50W4nji
#Natera #Signatera #MRD #PrecisionMedicine #Oncology
This is an exciting milestone as we continue advancing precision oncology and expanding access to innovative technology. ow.ly/KQcR50W4nji
#Natera #Signatera #MRD #PrecisionMedicine #Oncology
Natera Announces Medicare Coverage for Signatera™ Genome
Broad coverage, inclusive of all previously covered Signatera indications AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today ann...
ow.ly
July 15, 2025 at 9:18 PM
#Natera's journey: From IVF to pioneering genetic diagnostics. Mission-driven innovation transforming healthcare through interdisciplinary breakthroughs. Founders Matthew Rabinowitz & Jonathan Sheena, CEO Steve Chapman share on Sequoia #CrucibleMoments podcast.
ow.ly/eatK50UcfZh
#GeneticTesting
ow.ly/eatK50UcfZh
#GeneticTesting
Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution
Founder Matthew Rabinowitz opens up about the intensely personal journey that set him on a course to revolutionizing healthcare.
www.sequoiacap.com
December 3, 2024 at 5:31 PM